AI in Logistics and Supply Chain Management Market Report 2026

AI in logistics

Weighing this many data points while accounting for the many variables involved is nearly impossible for human cognitive functions. AI can assess demand in future supply chains and simulate anomaly events that could disrupt operations. If logistics and supply chains are to support these business process transformations, AI adoption becomes essential. Underpinning a large portion of businesses’ operations are robust logistics and supply chain transformations, which ensure the swift movement of goods and services globally.

best dealer management systems: Features, integrations, and top fit for your business

The technology enables cleaner transportation options through route optimization that cuts fuel consumption. McKinsey reports that dynamic optimization of routing https://power-at-work.com/lifts-streamlining-logistics-in-high-rise-construction-projects/ and freight contracting reduces both costs and environmental impact. AI provides data analytics for sustainable production, eco-friendly logistics, and greener supply chain practices.

  • The report, authored by Kearney and presented by Penske Logistics for the Council of Supply Chain Management Professionals, identifies five structural forces that continue to reshape the macro environment.
  • Resiliency of pharmaceutical supply chains has turned into a board level issue.
  • Companies must implement controlled data versioning, comply with privacy regulations, and balance cost with accuracy while protecting against malicious data manipulation that could skew AI performance.
  • AI-driven supply chain planning integrates machine learning, real-time data analytics, and external risk monitoring to anticipate disruptions before they materialize.

Top 11 AIaaS to Enhance Business Efficiency

The AI logistics pharma platforms are re-inventing the flow of pharmaceutical products across the global networks. The smart logistics pharma industry solutions are designed with AI that helps in optimizing routes, carrier selection, warehouse operation, and real-time monitoring of cold chains. AI will play a role in pharmaceutical inventory management in 2026 based on autonomous inventory optimization. AI will keep recalibrating reorder points, safety stock and allocation strategies on multi-echelon networks.

Terminal operating systems: Modules, features, and top providers

  • AI models help businesses analyze existing routing and track route optimization.
  • Companies using AI-based demand forecasting lower inventory holding costs while improving order fulfillment rates.
  • This makes the last mile busier than ever and ripe for a technology disruption.
  • Artificial intelligence in turn is quickly becoming a strategic enabler in the worlds of logistics, inventory control and the overall coordination of a supply chain.
  • Each category addresses distinct operational challenges and highlights significant opportunities.

Early adopters of warehouse automation achieve fulfillment accuracy rates exceeding 99.5%. The Tariff Chaos post covers how trade volatility is actually accelerating AI adoption in logistics by making manual decision-making too slow and too costly. That creates a compliance-meets-operations use case that teams should understand. Logistics ranks among the top three industries for AI ROI potential, averaging 190% returns on AI investments. The 35% adoption rate means early movers capture disproportionate competitive advantage.

AI in logistics

How artificial intelligence is transforming logistics

A digital twin is an imaginary replica of the physical supply chain, which responds to real-time processes, assets, and flows. Digital twins can be used to enable pharmaceutical firms to simulate situations, analyze the risks, and test their decisions before deploying them in the real world, all using AI. The AI inventory management pharma solutions are changing the manner in which businesses maintain balance between stock and working capital efficiency.

This system is now being expanded to mid-tier suppliers and transportation rate negotiations. Research shows up to 90% of routine logistics manager tasks are automatable (e.g., via tools like predictive analytics), while mechanics and technicians face low automation risk. The shift reduces clerical roles but boosts demand for data analysts, AI supervisors, and decision-makers.

Data sharing is both a technical and governance challenge — see our logistics AI governance guide for approaches to multi-party AI accountability. AI success has become an operating model challenge, not simply a tool to be implemented where available. Organizations that master integration, change management, and outcome measurement will pull ahead, while those waiting for better technology or lower prices will fall further behind.

Dynamic route optimization

  • Prolifics helps enterprises operationalize real-time intelligence by modernizing data pipelines, enabling AI-ready architectures, and embedding intelligence directly into operational workflows.
  • The technology becomes increasingly accurate in future load-to-carrier matchings as it learns from millions of performed transactions each day.
  • The greatest returns begin in back-office workflows and visibility enhancements, with expanding potential in warehouses, sorting, and last-mile delivery.
  • Collectively, these six categories enable logistics firms to target cost reductions between 10% and 25% percent across operational pools such as selling, general, and administrative (SG&A), last-mile delivery, sorting, and warehouse management.
  • This paper examines how AI-driven sustainment can transform logistics operations in the Indo-Pacific, aligning with the Army’s multi-domain operations (MDO) doctrine and ensuring combat effectiveness in a highly contested theater.

In 2026, labor shortages and surging e-commerce demand are accelerating adoption, with facilities reporting 25–30% reductions in labor costs and fulfillment rates up to three times faster than traditional methods. Autonomous systems and AI integration allow warehouses to maintain near-perfect accuracy while scaling operations efficiently across thousands of facilities. Companies are restructuring supplier networks, adopting just-in-case (JIC) inventory models, and implementing AI-driven forecasting to anticipate and mitigate disruptions. The objective is to maintain operational continuity while balancing cost efficiency with risk https://ulstergrandprix.net/meet-the-sponsors-ifs-logistics/ management.

It addresses the challenges posed when communications are denied, disrupted, intermittent, or limited, allowing units to continue operations without relying on central servers. Artificial intelligence is involved at the mission planning stage to create a route that bypasses Russian air defense zones. The Ministry of Defence explained that the neural network onboard the drones also helps distinguish decoys from combat equipment. The algorithm compares object geometry, surface characteristics and engine heat signatures to improve target identification and ensure effective use of the system.

AI in logistics

Because these areas yield fast results, businesses concentrate on risk management, freight optimization, and workflow automation. Despite shippers’ growing expectations that their LSP partners offer AI capabilities, AI adoption among LSPs still lags significantly. (See Exhibit 2.) About 40% report deploying AI beyond pilots, yet only one in ten have embedded AI into core operations at scale. Only 13% report measurable value—such as improvements in unit costs, service levels, or margins—from embedding AI into daily operations.

AI in logistics

AI in logistics involves analyzing vast amounts of data to optimize operations and reduce inefficiencies. The Corporate Sustainability Reporting Directive requires Scope 3 emissions reporting across logistics chains. AI-assisted emissions calculation must comply with European Sustainability Reporting Standards (ESRS) methodology and survive external audit. Logistics firms handling goods for CSRD-reporting customers face indirect compliance pressure even if they are below direct CSRD thresholds. The World Economic Forum’s 2025 Supply Chain Governance Report found that 78% of logistics companies lack contractual clarity on AI accountability in multi-party operations.

Analysis of X-ray Patterns in Infection and Tumor

Cases Series | Volume 7 | Issue 2 | JBST May – August  2021 | Page 5-8 | Dominic Puthoor. DOI:10.13107/jbst.2021.v07i02.47

Author: Dominic Puthoor[1]

[1]Department of Orthopaedic Oncologist, Amala Institute of Medical Sciences, Thrissur, Kerala, India.

Address of Correspondence
Dr. Dominic Puthoori,
Department of Orthopaedic Oncologist, Amala Institute of Medical Sciences, Thrissur, Kerala, India.
E-mail: dkputhur@gmail.com


Abstract

Introduction: In diagnosis of bone tumor, X-ray is as important, if not more important than pathology report. However, X-ray had specific disadvantage. Tumor mimics especially infection can have same appearance as tumor in the X-ray. In this article, author analyzes the different patterns of X-ray changes common to tumor and infection and points outs that X-ray depicts the aggressiveness of the condition rather than a specific diagnosis.

Keywords: X-ray, Bone tumor, Tumor mimics.


References:
1. Mandal AK, Chaudhary S. Text Book of Pathology. Synapse Books. 1st ed. New Delhi, India: Avichal Publishing Company; 2010. p. 51, 113.
2. Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran Pathological Basis of Diseases. Amsterdam, Netherlands: Elsevier; 2010. p. 1205-35.
3. Enneking WF, Bertoni F, The staging system for benign and malignant tumours of the musculoskeletal system. In: Nadarajan M, editors. Article Written in Principles of Orthopedic Oncology; 1997. p. 112-20.
4. Shimose S, Sugita T, Kubo T, Matsuo T, Nobuto H, Ochi M. Differential diagnosis between osteomyelitis and bone tumors. Acta Radiol 2008;49:928-33.
5. Stacy GS, Kapur A. Mimics of bone and soft tissue neoplasms. Radiol Clin North Am 2011;49:1261-86.
6. Dorman HD, Czerniak B. Bone Tumors. 1st ed. United States: Mosby; 1998. p. 22.
7. Puthur D. X-ray patterns common to infection and tumours. Kerala J Orthop 2014;27:73-7.
8. Malawer MM, Sugarbaker PH. Musculoskeletal Cancer Surgery: Treatment of Sarcomas and Allied Diseases. Berlin, Germany: Springer; 2001. p. 59, 60.
9. Sutton D. Text Book of Radiology and Imaging. 7th ed. United Kingdom: Churchill Livingstone; 2003. p. 1153-60.
10. Miwa S, Otsuka T. Practical use of imaging technique for management of bone and soft tissue tumors. J Orthop Sci 2017;22:391-400.


How to Cite this article: Puthoor D | Analysis of X-ray patterns in infection and tumor. | Journal of Bone and Soft Tissue Tumors | May-August 2021; 7(2): 5-8.

[Full Text HTML] [Full Text PDF] [XML]


Malignant Transformation of Monostotic Fibrous Dysplasia after Surgery: A Case Report

Case Report | Volume 7 | Issue 2 | JBST May- August 2021 | Page 1-4 | Abigail R. Tud, Cesar D. Dimayuga.

DOI:10.13107/jbst.2021.v07i02.46

Author: Abigail R. Tud[1], Cesar D. Dimayuga[1]

[1]Department of Orthopedics, The Medical City, Ortigas Avenue, Pasig City, Philippines 1605.

Address of Correspondence
Dr. Abigail R. Tud,
Musculoskeletal Tumor Unit, Philippine Orthopedic Center, Banawe corner Maria Clara Streets, Santa Mesa Heights, Quezon City, Metro Manila, Philippines 1114.
E-mail: abitud@gmail.com

 


Abstract

Introduction: Fibrous dysplasia (FD) is a benign lesion characterized by replacement of normal bone with abnormal connective tissue. It occurs in monostotic or polyostotic forms, with a rare but proven potential for malignant transformation. Symptoms of acute pain, rapid swelling, or an enlarging mass should increase suspicion for possible sarcomatous change. Complete surgical resection is the mainstay of treatment, and chemotherapy is recommended to improve survival.
Case Report: A 52-year-old male presented with a painful, enlarging mass on the right proximal thigh 2 years after undergoing plate fixation of the distal femur for a pathologic fracture secondary to monostotic FD. Diagnostic imaging revealed signs of recurrence, and core needle biopsy revealed aggressive features suggestive of malignant transformation. Following surgical resection and chemotherapy, the outcome has been uneventful without evidence of recurrence or metastasis at 4-year post-operation.
Conclusion: Malignant transformation in monostotic FD is rare. Symptom exacerbation should increase the suspicion for sarcomatous change and prompt the need for diagnostic imaging as well as histologic confirmation.
Keywords: Fibrosarcoma, fibrous dysplasia, malignant transformation, secondary sarcoma.


References:
1. Picci P, Sieberova G, Alberghini M, Balladelli A, Vanel D, Hogendoorn PC, et al. Late sarcoma development after curettage and bone grafting of benign bone tumors. Eur J Radiol 2011;77:19-25.
2. Muthusamy S, Conway SA, Subhaeong TY, Temple HT. Locally aggressive fibrous dysplasia mimicking malignancy: A report of four cases and review of the literature. Clin Orthop Relat Res 2015;473:742-50.
3. Qu N, Yao W, Cui X, Zhang H. Malignant transformation in monostotic fibrous dysplasia: Clinical features, imaging features, outcomes in 10 patients, and review. Medicine (Baltimore) 2015;94:e369.
4. Mardekian SK, Tuluc M. Malignant sarcomatous transformation of fibrous dysplasia. Head Neck Pathol 2015;9:100-3.
5. Riddle ND, Bui MM. Fibrous dysplasia. Arch Pathol Lab Med 2013;137:8-21.
6. Ruggieri P, Sim FH, Bond JR, Unni KK. Malignancies in fibrous dysplasia. Cancer 1994;73:1411-24.
7. Chapurlat RD, Gensburger D, Jimenez-Andrade JM, Ghilardi JR, Kelly M, Mantyh P. Pathophysiology and medical treatment of pain in fibrous dysplasia of bone. Orphanet J Rare Dis 2012;7:S3.
8. Doqanavsarqil B, Argin M, Kececi B, Sezak M, Sanli UA, Oztop F. Secondary osteosarcoma arising in fibrous dysplasia, case report. Arch Orthop Trauma Surg 2009;129:439-44.
9. Stanton RP, Ippolito E, Springfield D, Lindaman L, Wientroub S, Leet A. The surgical management of fibrous dysplasia of bone. Orphanet J Rare Dis 2012;7 Suppl 1:S1.
10. Hatano H, Morita T, Arllzumi T, Kawashima H, Ogose A. Malignant transformation of fibrous dysplasia: A case report. Oncol Lett 2014;8:384-6.
11. National Comprehensive Cancer Network (NCCN). Bone Cancer, NCCN Guidelines; 2013. Available from: http://www.nccn.org. [Last accessed on 2016 Mar 16].


How to Cite this article: Tud AR, Dimayuga CD| Malignant Transformation of Monostotic Fibrous Dysplasia after Surgery: A Case Report | Journal of Bone and Soft Tissue Tumors | May-Aug 2021; 7(2): 1-4.

[Full Text HTML] [Full Text PDF] [XML]


Submit Article

Submit Manuscript

Currently, JBST is accepting submissions only by its article submission System “Scripture”

For more Information regarding SCRIPTURE – Click Here

Already have a Username/Password for Scripture?
GO TO LOGIN

Need a Username/Password for Scripture?
GO TO REGISTRATION

Registration and login to SCRIPTURE is required to submit articles to the Journal of Bone and Soft Tissue Tumors and to check the status of current submissions.

In case of any Queries regarding SCRIPTURE, please write to us at editor.jbst@gmail.com

Format all articles according to Journal Guidelines: Click here for Journal Guidelines

Copyright Letter: Download Here

Conflict of Interest forms: Download Here  

(Conflict of Interest form– COI is a special document. we can’t open it on the browser. To download the form click on the link provided and use the option as seen in the above picture )

Conflict of Interest forms are according to Guidelines by the International Committee of Medical Journal Editors and Each Authors details have to be filled separately and submitted with the manuscript. Plagiarism is not permitted and Journal will check every article for plagiarism using ‘Plagtracker’ and google search.

Article submission Charges: None

Article Publishing charges: 5000 INR or 150 $ (for international article). The publishing charges have to be paid only on acceptance of the article]

JBST will maintain the open access policy and will continue to run with contribution from authors and donations from IORG

Distal Ulnar Translocation with Partial Wrist Arthrodesis for Grade III Campanacci Giant Cell Tumors of the Distal Radius – A Case Series

Cases Series | Volume 7 | Issue 1 | JBST January – April 2021 | Page 12-15 | Sivakumar Raju, Prahalad Kumar Singhi, M. Chidambaram, V. Somashekar. DOI: 10.13107/jbst.2021.v0701.43

Author: Sivakumar Raju[1], Prahalad Kumar Singhi[1], M. Chidambaram[1], V. Somashekar[1]

[1]Department of Orthopaedic, Preethi Hospitals Pvt. Ltd., 50 Melur Main Road, Uthangudi, Madurai, Tamil Nadu, India.

Address of Correspondence
Dr. Prahalad Kumar Singhi,
Consultant Arthroscopy and Trauma Surgeon, Preethi Hospitals Pvt. Ltd., Madurai – 625 107, Tamil Nadu, India.
E-mail: docpsin2001@yahoo.co.in


Abstract

Introduction: Campanacci Grade III giant cell tumor of distal radius is an uncommon condition with limited treatments options and ulnar translocation is one.
Materials and Methods: We retrospectively analyzed five cases of Campanacci Grade III tumor in which three were recurrent cases, four female and one male all operated under regional anesthesia (supraclavicular brachial plexus block) with en bloc resection and reconstruction using ulnar translocation with fusion only with proximal carpal row from 2012 to 2018 at our institute. The mean length of tumor resected was 6.74 cm and average follow-up of 60 months. Average union time at radioulnar junction was 4–5 months and ulnocarpal joint was 3–4 months.
Results: Functional outcome was assessed using musculoskeletal tumor society scoring system, 80% had excellent and good outcome, and one patient had extensive recurrence and ended up in below-elbow amputation.
Conclusion: Ulnar translocation with partial wrist arthrodesis is a simple, valid, option with acceptable appearance of forearm, useful wrist function, no donor site morbidity nor need for a microvascular procedure, and no need to achieve complete wrist arthrodesis as compared to other options for reconstruction.
Keywords: Distal radius giant cell tumor, Campanacci Grade III tumor, modified ulnar translocation, partial wrist arthrodesis.


Reference:
1. Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. JBone Joint Surg [Am] 1987;69-A:106-14.
2. Vander Griend RA, Funderburk CH. The treatment of giant-cell tumors of the distal part of the radius. J Bone Joint Surg [Am] 1993;75-A:899-908.
3. Sheth DS, Healey JH, Sobel M, Lane JM, Marcove RC. Giant cell tumor of the distal radius. J Hand Surg [Am] 1995;20:432-40.
4. Khan MT, Gray JM, Carter SR, Grimer RJ, Tillman RM. Management of the giant-cell tumours of the distal radius. Ann R Coll Surg Engl 2004;86:18-24.
5. Harness NG, Mankin HJ. Giant-cell tumor of the distal forearm. J Hand Surg Am. 2004; 29(2):188-193.Cheng CY, Shih HN, Hsu KY, Hsu RW. Treatment of giant cell tumor of the distal radius.Clin Orthop Relat Res. 2001; (383):221-228.
6. Gitelis S, Mallin BA, Piasecki P, Turner F. Intralesional excision compared with en bloc resection for giant-cell tumors of bone. J Bone Joint Surg Am. 1993; 75(11):1648-1655.
7. O’Donnell RJ, Springfield DS, Motwani HK, Ready JE, Gebhardt MC, Mankin HJ. Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg Am. 1994: 76(12):1827-1833.
8. Kocher MS, Gebhardt MC, Mankin HJ. Reconstruction of the distal aspect of the radius with use of an osteoarticular allograft after excision of a skeletal tumor. J Bone Joint Surg Am. 1998; 80(3):407-419.
9. Szabo RM, Anderson KA, Chen JL. Functional outcome of en bloc excision and osteoarticular allograft replacement with the Sauve-Kapandji procedure for Campanacci grade 3 giant-cell tumor of the distal radius. J Hand Surg Am. 2006; 31(8):1340-1348.
10. Lalla RN, Bhupathi SC. Treatment of giant cell tumor of the distal radius by ulnar translocation. A case report and review of the literature. Orthopedics. 1987; 10(5):735-739.
11. Seradge H. Distal ulnar translocation in the treatment of giant-cell tumors of the distal end of the radius. J Bone Joint Surg Am. 1982; 64(1):67-73.
12. Bhan S, Biyani A. Ulnar translocation after excision of giant cell tumour of distal radius. J Hand Surg Br. 1990; 15(4):496-500.
13. Ono H, Yajima H, Mizumoto S, et al. Vascularized fibular graft for reconstruction of the wrist after excision of giant cell tumor. Plast Reconstr Surg 1997;99:1086-93.
14. Bhagat S, Bansal M, Jandhyala R, et al. Wide excision and ulno-carpal arthrodesis for primary aggressive and recurrent giant cell tumours. Int Orthop 2008;32:741-5.
15. Natarajan MV, Chandra Bose J, Viswanath J, Balasubramanian N, Sameer M. Custom prosthetic placement for distal radial tumours. Int Orthop 2009;33:1081-4.
16. Seradge H. Distal ulnar translocation in the treatment of giant-cell tumors of the distal end of the radius. J Bone Joint Surg [Am] 1982;64-A:67-73.
17. Chalidis BE, Dimitriou CG. Modified ulnar translocation technique for the reconstruction of giant cell tumour of the distal radius. Orthopedics 2008;31:608.
18. Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop 1993;286:241-6.
19. Asavamongkolkul A, Waikakul S, Phimolsarnti R, Kiatisevi P. Functional outcome following excision of a tumour and reconstruction of the distal radius. Int Orthop 2009;33:203
20. SK Saraf, SC Goel, Complications of resection and reconstruction in giant cell tumour of distal end of radius – An analysis, IJO, October 2005, Volume 39: Number 4: P.206-211
21. WILSON, P. D., and LANCE, E. M.: Surgical Reconstruction of the Skeleton following Segmental Resection for Bone Tumors. J. Bone and Joint Surg., 47-A: 1629-1656, Dee. 1965
22. A.Puri, Ulnar translocation after excision of a Campanacci grade III giant cell tumour of the distal radius, JBJS (br) 2010; 92-B-875-9
23. Turcotte RE, Wunder JS, Isler MH, et al. Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res. 2002; (397):248-258.
24. Zou C, Lin T, Wang B, et al. Managements of giant cell tumor within the distal radius: A retrospective study of 58 cases from a single center. J Bone Oncol. 2018;14:100211. Published 2018 Dec 14. doi:10.1016/j.jbo.2018.100211.


How to Cite this article: Raju S, Singhi PK, Chidambaram M, Somashekar V | Distal Ulnar Translocation with Partial Wrist Arthrodesis for Grade III Campanacci Giant Cell Tumors of the Distal Radius – A Case Series | Journal of Bone and Soft Tissue Tumors | Jan-Apr 2021; 7(1): 12-15.

[Full Text HTML] [Full Text PDF] [XML]


A Case Report of Solitary Bone Metastasis from Primary Angiosarcoma of the Bilateral Breasts – A Rare Diagnosis

Case Report | Volume 7 | Issue 1 | JBST January – April 2021 | Page 16-21 | Katrina Ysabel R Naraval, Daniela Kristina D. Carolino, Ma. Lilia Molina P. Jose. DOI: 10.13107/jbst.2021.v07i01.43

Author: Katrina Ysabel R Naraval[1], Daniela Kristina D. Carolino[1], Ma. Lilia Molina P. Jose[1], [2]

[1]Institute of Orthopaedics and Sports Medicine, St. Luke’s Medical Center, 279 E. Rodriguez Sr. Blvd., Quezon city 1112, Philippines,
[2]Orthopaedic Oncology section, Department of Orthopaedics, The Medical City Clark, Pampanga, Philippines.

Address of Correspondence
Dr. Katrina Ysabel R Naraval,
Institute of Orthopaedics and Sports Medicine, St. Luke’s Medical Center, 279 E. Rodriguez Sr. Blvd., Quezon city 1112, Philippines.
E-mail: khayanaraval@gmail.com


Abstract

Introduction: Primary angiosarcoma of the breast is an uncommon subtype of soft-tissue sarcoma known to be aggressive and is associated with distant metastasis and poor prognosis. Solitary bone metastases occurring in these cases are even more rare with the available limited literature based from small retrospective case series.
Case Report: We present a case of a 24-year-old Filipino female previously diagnosed with primary angiosarcoma of the bilateral breasts, initially presenting with a 3-month history of the right hip pain and consulted due to a pathologic fracture of the right proximal femur. Diagnostic tests done confirmed solitary skeletal metastasis to this area, for which she underwent wide resection and application of a proximal femoral endoprosthesis. Postoperatively, the patient was able to independently ambulate, with follow-up radiographs showing stable implant fixation. Further imaging showed that lesion-free bones, however, noted development of distant recurrence manifesting with pulmonary metastases and hemorrhagic subcutaneous lesions 3 months after. Adequate tumor resection and radiotherapy are reported to successfully treat isolated skeletal metastasis in the proximal femur. The presence of the pathologic fracture before definitive treatment may have contributed to its distant recurrence, in addition to an already aggressive nature of the primary malignancy.
Conclusion: In the background of primary breast angiosarcoma, although rare, high suspicion for isolated skeletal metastasis in a symptomatic patient prevents delay in definitive management, which avoids progression to a poorer prognosis.
Keywords: Solitary bone metastasis, angiosarcoma, proximal femur, pathologic fracture.


References:

1. Bordoni D, Bolletta E, Falco G, Cadenelli P, Rocco N, Tessone A, et al. Primary angiosarcoma of the breast. Int J Surg Case Rep 2016;20:12-5.
2. An I, Harman M, Ibiloglu I. Topical ciclopirox olamine 1%: Revisiting a unique antifungal. Indian Dermatol Online J 2017;10:481-5.
3. Kunkiel M, Maczkiewicz M, Jagiełło-Gruszfeld A, Nowecki Z. Primary angiosarcoma of the breast-series of 11 consecutive cases-a single-centre experience. Curr Oncol 2018;25:e50-3.
4. Bhosale SJ, Kshirsagar AY, Patil MV, Wader JV, Nangare N, Patil PP. Primary angiosarcoma of breast: A case report. Int J Surg Case Rep 2013;4:362-4.
5. Zahir ST, Sefidrokh Sharahjin N, Rahmani K. Primary breast angiosarcoma: Pathological and radiological diagnosis. Malays J Med Sci 2014;21:66-70.
6. Gaballah AH, Jensen CT, Palmquist S, Pickhardt PJ, Duran A, Broering G, et al. Angiosarcoma: Clinical and imaging features from head to toe. Br J Radiol 2017;90:20170039.
7. Wang L, Lao IW, Yu L, Wang J. Clinicopathological features and prognostic factors in angiosarcoma: A retrospective analysis of 200 patients from a single Chinese medical institute. Oncol Lett 2017;14:5370-8.
8. Hosaka S, Katagiri H, Honda Y, Wasa J, Murata H, Takahashi M. Clinical outcome for patients of solitary bone only metastasis. J Orthop Sci 2016;21:226-9.
9. Vincenzi B, Santini D, Schiavon G, Frezza AM, Dileo P, Silletta M, et al. Bone metastases in soft tissue sarcoma patients: A survey of natural, prognostic value, and treatment. J Clin Oncol 2012;30 Suppl 15:10063.
10. Guzik G. Oncological and functional results after surgical treatment of bone metastases at the proximal femur. BMC Surg 2018;18:2-9.
11. Li N, Cusidó MT, Navarro B, Tresserra F, Baulies S, Ara C, et al. Breast sarcoma. A case report and review of literature. Int J Surg Case Rep 2016;24:203-5.
12. Saimura M, Mitsuyama S, Anan K, Koga K, Ono M, Toyoshima S. A rare case of rapidly progressing angiosarcoma of the breast with multiple metastases to the bone, liver, ovary, and gingiva. Int Cancer Conf J 2012;1:159-63.
13. Soeharno H, Povegliano L, Choong PF. Multimodal treatment of bone metastasis-a surgical perspective. Front Endocrinol (Lausanne) 2018;9:518.
14. Khattak MJ, Ashraf U, Nawaz Z, Noordin S, Umer M. Surgical management of metastatic lesions of proximal femur and the hip. Ann Med Surg (Lond) 2018;36:90-5.
15. Pramanik R, Gogia A, Malik PS, Gogi R. Metastatic primary angiosarcoma of the breast: Can we tame it the metronomic way. Indian J Med Paediatr Oncol 2017;38:228-31.
16. Apice G, Pizzolorusso A, di Maio M, Grignani G, Gebbia V, Buonadonna A, et al. Confirmed activity and tolerability of weekly paclitaxel in the treatment of advanced angiosarcoma. Sarcoma 2016;2016:6862090.
17. Yu Z, Xiong Y, Shi R, Min L, Zhang W, Liu H, et al. Surgical management of metastatic lesions of the proximal femur with pathological fractures using intramedullary nailing or endoprosthetic replacement. Mol Clin Oncol 2017;8:107-14.
18. Sarahrudi K, Hora K, Heinz T, Millington S, Vécsei V. Treatment results of pathological fractures of the long bones: A retrospective analysis of 88 patients. Int Orthop 2006;30:519-24.


How to Cite this article: Naraval KYR, Carolino DKD, Jose MLMP | A Case Report of Solitary Bone Metastasis from Primary Angiosarcoma of the Bilateral Breasts – A Rare Diagnosis | Journal of Bone and Soft Tissue Tumors | Jan-Apr 2021; 7(1): 16-21.

[Full Text HTML] [Full Text PDF] [XML]